Oligoarginine-PEG-lipid particles for gene delivery

Cell-penetrating peptides (CPPs) are small peptides that can facilitate the uptake of macromolecular drugs, such as proteins or nucleic acids, into mammalian cells. Cytosolic delivery of CPPs could be beneficial to bypass conventional endocytosis in order to avoid degradation in the lysosomes. Oligoarginine conjugates have characteristics similar to CPPs in terms of cell translocation and are used in the intracellular delivery of plasmid DNA. In these cases, oligoarginine length and/or charge are important factors in the cellular uptake of oligoarginine alone. The arginine moiety of oligoarginine-modified particles may also be a decisive factor for vectors to deliver plasmid DNA. Oligoarginine-PEG-lipids can form self-assembled particles and modify the surface of lipid- and polymer-based particles. This review focuses on the influence of: i) oligoarginine-modified particles such as micelles, liposomes and polymer-based particles; ii) the morphology of oligoarginine-PEG-lipid complexed with plasmid DNA by decreasing the charge ratio; and iii) the oligoarginine length in the complex on its cellular uptake, transfection efficiency and uptake mechanism. The oligoarginine length of oligoarginine-modified particle complexed with plasmid DNA governs the cellular uptake pathway that determines the destiny of intracellular trafficking and finally transfection efficiency. The new aspects of surface-functionalized particle vectors with oligoarginine are discussed.

[1]  H Harashima,et al.  Stearylated arginine-rich peptides: a new class of transfection systems. , 2001, Bioconjugate chemistry.

[2]  A. Prochiantz,et al.  The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.

[3]  Y. Maitani,et al.  Calcium enhanced delivery of tetraarginine-PEG-lipid-coated DNA/protamine complexes. , 2009, International journal of pharmaceutics.

[4]  K. Sakurai,et al.  Transition from a normal to inverted cylinder for an amidine-bearing lipid/pDNA complex and its excellent transfection. , 2005, Bioconjugate chemistry.

[5]  K. Ulbrich,et al.  Polymer‐coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction , 2004, The journal of gene medicine.

[6]  M. Giacca,et al.  Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. , 2004, The Journal of biological chemistry.

[7]  D. Porteous,et al.  HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Steven F Dowdy,et al.  Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Steven F. Dowdy,et al.  Cell Penetrating Peptides in Drug Delivery , 2004, Pharmaceutical Research.

[10]  Y. Tseng,et al.  Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.

[11]  H Akita,et al.  Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid , 2007, Gene Therapy.

[12]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[13]  Yaping Li,et al.  Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency. , 2008, International journal of pharmaceutics.

[14]  M. Conese,et al.  Gene Transfer by Means of Lipo- and Polyplexes: Role of Clathrin and Caveolae-Mediated Endocytosis , 2006, Journal of liposome research.

[15]  S. W. Kim,et al.  Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  R. Schwendener,et al.  Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes , 2004, Cellular and Molecular Life Sciences CMLS.

[17]  L. Tönges,et al.  Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons. , 2006, RNA.

[18]  Jong-sang Park,et al.  Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. , 2007, Biomaterials.

[19]  E. Vivés Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions. , 2003, Journal of molecular recognition : JMR.

[20]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[21]  K. Leong,et al.  Biodegradable polyphosphoester micelles for gene delivery. , 2004, Journal of pharmaceutical sciences.

[22]  Norased Nasongkla,et al.  Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.

[23]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[24]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[25]  Y. Mély,et al.  Gene transfer by cationic surfactants is essentially limited by the trapping of the surfactant/DNA complexes onto the cell membrane: a fluorescence investigation. , 2000, Biochimica et biophysica acta.

[26]  I. Khalil,et al.  Novel lipidated sorbitol-based molecular transporters for non-viral gene delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[27]  V. Torchilin,et al.  siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene , 2006, Journal of Controlled Release.

[28]  G. Zuber,et al.  Monomolecular DNA nanoparticles for intravenous delivery of genes. , 2005, Journal of the American Chemical Society.

[29]  G. Elliott,et al.  Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.

[30]  C. Contag,et al.  Gene transfer via reversible plasmid condensation with cysteine-flanked, internally spaced arginine-rich peptides. , 2003, Human gene therapy.

[31]  U. Greber,et al.  Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake , 2002, The Journal of cell biology.

[32]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[33]  S. Zeng,et al.  A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. , 2006, International journal of pharmaceutics.

[34]  Dong-Eun Kim,et al.  Evaluation of generations 2, 3 and 4 arginine modified PAMAM dendrimers for gene delivery. , 2008, International journal of pharmaceutics.

[35]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[36]  S. Takeoka,et al.  Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. , 2008, Bioconjugate chemistry.

[37]  Jeremy C Simpson,et al.  Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[38]  W. Seeger,et al.  Effects of cell‐penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs , 2008, The journal of gene medicine.

[39]  W. Moerner,et al.  Single-molecule motions of oligoarginine transporter conjugates on the plasma membrane of Chinese hamster ovary cells. , 2008, Journal of the American Chemical Society.

[40]  M. Bally,et al.  Self-Assembling DNA-Lipid Particles for Gene Transfer , 1997, Pharmaceutical Research.

[41]  Y. Maitani,et al.  High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[42]  P. Searle,et al.  Vectors based on reducible polycations facilitate intracellular release of nucleic acids , 2003, The journal of gene medicine.

[43]  Y. Maitani,et al.  Intracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine length. , 2006, Bioconjugate chemistry.

[44]  V. Torchilin,et al.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Raines,et al.  Pathway for polyarginine entry into mammalian cells. , 2004, Biochemistry.

[46]  Ü. Langel,et al.  Cell-Penetrating Peptides , 2000, Methods in Molecular Biology.

[47]  E. Brambilla,et al.  An electron microscopy study into the mechanism of gene transfer with lipopolyamines. , 1996, Gene therapy.

[48]  P. Cullis,et al.  Calcium enhances the transfection potency of plasmid DNA-cationic liposome complexes. , 2000, Biochimica et biophysica acta.

[49]  W. Jiskoot,et al.  OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. , 2004, Biochimica et biophysica acta.

[50]  A. Prochiantz,et al.  Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent* , 1996, The Journal of Biological Chemistry.

[51]  M. Ferrer,et al.  Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. , 2005, Biochimica et biophysica acta.

[52]  H. Riezman,et al.  Molecular Mechanisms of Endocytosis , 1997, Cell.

[53]  D. Scherman,et al.  Virus-sized self-assembling lamellar complexes between plasmid DNA and cationic micelles promote gene transfer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  L. Huang,et al.  Direct gene transfer to mouse melanoma by intratumor injection of free DNA. , 1996, Gene therapy.

[55]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[56]  H Harashima,et al.  Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation , 2004, Gene Therapy.

[57]  Shiroh Futaki,et al.  High Density of Octaarginine Stimulates Macropinocytosis Leading to Efficient Intracellular Trafficking for Gene Expression* , 2006, Journal of Biological Chemistry.

[58]  R. Müller,et al.  Oligomers of the Arginine-rich Motif of the HIV-1 TAT Protein Are Capable of Transferring Plasmid DNA into Cells* 210 , 2003, The Journal of Biological Chemistry.

[59]  M. Manning,et al.  Long chain arginine esters: a new class of cationic detergents for preparation of hydrophobic ion-paired complexes. , 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[60]  Y. Maitani,et al.  Design, synthesis and gene delivery efficiency of novel oligo-arginine-linked PEG-lipids: effect of oligo-arginine length. , 2005, International journal of pharmaceutics.

[61]  Dale L. Greiner,et al.  T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2008, Cell.

[62]  W. Seeger,et al.  Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[63]  P. Reynier,et al.  In Vitro and In Vivo Transfection of Melanoma Cells B16-F10 Mediated by Cholesterol-based Cationic Liposomes , 2002, Journal of drug targeting.

[64]  Y. Maitani,et al.  Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG. , 2009, International journal of pharmaceutics.

[65]  A. Rees,et al.  Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides* , 2003, Journal of Biological Chemistry.

[66]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  L. Medina-Kauwe,et al.  Intracellular trafficking of nonviral vectors , 2005, Gene Therapy.

[68]  K. Hruska,et al.  Protein transduction: unrestricted delivery into all cells? , 2000, Trends in cell biology.

[69]  R. Fischer,et al.  A quantitative validation of fluorophore-labelled cell-permeable peptide conjugates: fluorophore and cargo dependence of import. , 2002, Biochimica et biophysica acta.

[70]  D. Scherman,et al.  Design, synthesis, and evaluation of gadolinium cationic lipids as tools for biodistribution studies of gene delivery complexes. , 2003, Bioconjugate chemistry.

[71]  B. Franc,et al.  Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through cell surface protease activation. , 2006, Bioconjugate chemistry.

[72]  E. Vivés Cellular utake of the Tat peptide: an endocytosis mechanism following ionic interactions , 2003 .

[73]  D. Pezzoli,et al.  A dimerizable cationic lipid with potential for gene delivery , 2008, The journal of gene medicine.

[74]  B. Deurs,et al.  Phorbol myristate acetate selectively stimulates apical endocytosis via protein kinase C in polarized MDCK cells. , 1995, Experimental cell research.

[75]  M. Morris,et al.  A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.

[76]  Yasuhiro Tsume,et al.  Bile acid-oligopeptide conjugates interact with DNA and facilitate transfection. , 2007, Molecular pharmaceutics.

[77]  R. Fischer,et al.  A Stepwise Dissection of the Intracellular Fate of Cationic Cell-penetrating Peptides* , 2004, Journal of Biological Chemistry.

[78]  E Marshall,et al.  Gene Therapy Death Prompts Review of Adenovirus Vector , 1999, Science.

[79]  K. Pattabiraman,et al.  The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[80]  K. L. Douglas Toward Development of Artificial Viruses for Gene Therapy: A Comparative Evaluation of Viral and Non‐viral Transfection , 2008, Biotechnology progress.

[81]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[82]  J. Rothbard,et al.  Polyarginine enters cells more efficiently than other polycationic homopolymers. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[83]  J. Behr,et al.  Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. , 2001, Journal of the American Chemical Society.

[84]  D. Song,et al.  Marked transfection enhancement by the DPL (DNA/peptide/lipid) complex. , 2007, International journal of molecular medicine.

[85]  S. W. Kim,et al.  Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. , 2009, Biomaterials.

[86]  K. Nagayama,et al.  Decaarginine-PEG-artificial lipid/DNA complex for gene delivery: nanostructure and transfection efficiency. , 2008, Journal of nanoscience and nanotechnology.

[87]  T. Chen,et al.  Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. , 2003, Biochimica et biophysica acta.

[88]  Hans P Merkle,et al.  On the biomedical promise of cell penetrating peptides: limits versus prospects. , 2008, Journal of pharmaceutical sciences.

[89]  D. Friend,et al.  Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. , 1996, Biochimica et biophysica acta.

[90]  A. Sochanik,et al.  A new cholesterol derivative suitable for transfecting certain type of cells in the presence of 10% serum , 2000, Cancer Gene Therapy.

[91]  K. Sandvig,et al.  Membrane ruffling and macropinocytosis in A431 cells require cholesterol. , 2002, Journal of cell science.

[92]  H Akita,et al.  Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery , 2007, Gene Therapy.

[93]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.